---
figid: PMC7066582__nihms-1564922-f0003
figtitle: Retinoid signaling pathways leading to lung cancer stem cell (CSC) differentiation
  and cell cycle arrest
organisms:
- Homo sapiens
- Mus musculus
- Nicotiana tabacum
pmcid: PMC7066582
filename: nihms-1564922-f0003.jpg
figlink: pmc/articles/PMC7066582/figure/F3/
number: F3
caption: Retinol binds with retinol binding protein (RBP) and translocates into lung
  cancer cells by retinoic acid gene 6 (STRA6) receptor mediated endocytosis or diffusion.
  Inside the cell, it interacts with cellular retinol binding protein (CRBP) and oxidizes
  into RA by enzyme retinol dehydrogenase (RDH). RA inhibits the EGFR/Wnt pathways
  via activation of transcription factor GATA-binding factor 6 (GATA6). GATA6 upregulates
  the expression of (SEPTB), mucin4 (MUC4), frizzled class receptor 2 (FZD2) and downregulates
  the expression of epidermal growth factor receptor (EGFR), catenin beta (CTNNB),
  and cyclin D1. Importantly, EGFR and CTNNB downregulation inhibit the activation
  of the Wnt signaling pathway; however, downregulation of cyclin D1 promotes lung
  CSC differentiation and cell cycle arrest. Furthermore, RA alone may promote cancer
  cell survival, proliferation, migration, and invasion via activation of PI3-Akt/ERK
  pathways. Combinatorial treatment of RA with PI3K/ERK inhibitors represses these
  pro-cancer effects of RA in lung tumours.
papertitle: 'The potential of retinoids for combination therapy of lung cancer: Updates
  and future directions.'
reftext: Surya Kant Tripathi, et al. Pharmacol Res. ;147:104331-104331.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9651967
figid_alias: PMC7066582__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7066582__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7066582__nihms-1564922-f0003.html
  '@type': Dataset
  description: Retinol binds with retinol binding protein (RBP) and translocates into
    lung cancer cells by retinoic acid gene 6 (STRA6) receptor mediated endocytosis
    or diffusion. Inside the cell, it interacts with cellular retinol binding protein
    (CRBP) and oxidizes into RA by enzyme retinol dehydrogenase (RDH). RA inhibits
    the EGFR/Wnt pathways via activation of transcription factor GATA-binding factor
    6 (GATA6). GATA6 upregulates the expression of (SEPTB), mucin4 (MUC4), frizzled
    class receptor 2 (FZD2) and downregulates the expression of epidermal growth factor
    receptor (EGFR), catenin beta (CTNNB), and cyclin D1. Importantly, EGFR and CTNNB
    downregulation inhibit the activation of the Wnt signaling pathway; however, downregulation
    of cyclin D1 promotes lung CSC differentiation and cell cycle arrest. Furthermore,
    RA alone may promote cancer cell survival, proliferation, migration, and invasion
    via activation of PI3-Akt/ERK pathways. Combinatorial treatment of RA with PI3K/ERK
    inhibitors represses these pro-cancer effects of RA in lung tumours.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Stra6
  - Akt1
  - Pik3r1
  - Rara
  - Rbp1
  - Ephb2
  - Mapk1
  - Gata6
  - Ccnd1
  - Muc4
  - Egfr
  - Fzd2
  - dm
  - da
  - Trp53
  - Rarb
  - RENBP
  - SUGP1
  - STRA6
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RARA
  - RBP1
  - SORD
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - EPHB2
  - MAPK1
  - MAPK3
  - CRABP1
  - MTG1
  - GATA6
  - CCND1
  - MUC4
  - EGFR
  - CTNNB1
  - FZD2
  - TP53
  - TP63
  - TP73
  - RARB
  - Retinol
  - DM
---
